Skip to main content
Clinical Trials/NCT01942486
NCT01942486TerminatedNot Applicable

Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Child and Adolescent Patients With Migraine

University of Utah1 site in 1 country35 target enrollmentStarted: January 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
35
Locations
1
Primary Endpoint
HIT-6 Score

Study Overview

Brief Summary

The purpose of this study is to determine if a special coating, applied to the surface of glasses can reduce the frequency and severity of migraine headaches in children and adolescents. This study is being conducted by researchers at Primary Children's Medical Center, The John Moran Eye Center, and the University of Utah Department of Electrical Engineering. The investigators have determined that a specific frequency of light is particularly bothersome to migraine patients. The coating they've developed is designed to block this frequency of light. Very few treatments are approved for the treatment of childhood migraine. The investigators hope that these glasses will provide a safe way to improve headaches in children.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
7 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Must be diagnosed with migraine with aura or migraine without aura
  • •Must have at least 10 headache days per month

Exclusion Criteria

  • •Currently wearing a spectacle tint specifically prescribed for migraine or light sensitivity
  • •Unwilling or unable in the judgment of the investigator to complete the study
  • •Unavailable for any of the study visits
  • •Light sensitive conditions: meningitis, iritis, blepharospasm, albinism
  • •Degenerative diseases of the retina or optic nerve: diabetic retinopathy, ischemic optic neuropathy
  • •Medications known to affect retinal or optic nerve function: hydroxychloroquine, chloroquine, ethambutol, amiodarone, erectile dysfunction drugs
  • •Best corrected visual acuity less than 20/40 in either eye

Arms & Interventions

Investigational Coating

Experimental

Intervention: Investigational Coating (Device)

Outcomes

Primary Outcomes

HIT-6 Score

Time Frame: 12 weeks

The HIT-6 (Headache Impact Test) is a validated measure of the impact of headache on activities of daily living, functional health and well-being. The minimum score is 36 and the maximum score is 78. The higher the score, the more your headaches are adversely affecting activities of daily living. Patients who score higher than 50 are encouraged to seek help from their physician.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Bradley Katz

M.D.

University of Utah

Study Sites (1)

Loading locations...

Similar Trials